Stockreport

Moa Technology hires for further growth with expansion of its leadership team – announcing appointment of CFO and US-based CBO to support advancement of next-generation herbicides

Silence Therapeutics Plc - American Depository Share  (SLN) 
PDF Experienced biotech Chief Financial Officer (CFO) Dr. Rob Quinn appointed as Oxford-based Moa develops its strong pipeline of next-generation herbicides and continues to [Read more]